Advertisement

Topics

Rhodanine-based compounds show inhibitory activity to prevent aggregation of Tau proteins

16:36 EDT 30 Jun 2017 | News-Medical.net

The design of tailored peptide-polymer conjugates as drug-specific formulation additives offers access to next generation precision additives that can render problematic small organic drugs water-soluble and improve bioavailability.

Original Article: Rhodanine-based compounds show inhibitory activity to prevent aggregation of Tau proteins

NEXT ARTICLE

More From BioPortfolio on "Rhodanine-based compounds show inhibitory activity to prevent aggregation of Tau proteins"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...